Abstract LB-224: Anti-tumor effects of ECP-1014 in combination with erlotinib in HT-29 xenograft murine colon carcinoma model
Bobby W. Sandage, John J. Talley, Yican Wang(Guangzhou Institutes of Biomedicine and Health), Yanmei Zhang(China Agricultural University), Zhengchao Tu(Chinese Academy of Sciences), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Micky D. Tortorella(Pfizer (United States))
Cited by 1
Related Papers
Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family
|Journal of Biological Chemistry|1999|488
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5
|Arthritis & Rheumatism|2007|403
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
|Osteoarthritis and Cartilage|2001|324
Aggrecan Protects Cartilage Collagen from Proteolytic Cleavage
|Journal of Biological Chemistry|2003|294
Inhibition of ADAM-TS4 and ADAM-TS5 Prevents Aggrecan Degradation in Osteoarthritic Cartilage
|Journal of Biological Chemistry|2002|294